Back to all Presentations

Redeye interview with CEO Kristina Torfgård

Date: 2021-03-01

Alzinova's CEO Kristina Torfgård was interviewed on February 26, 2021 by Redeye’s Life Science analyst Anders Hedlund.

In this interview, Kristina talks about highlights from Alzinova’s year-end report 2020, the upcoming clinical study with therapeutic vaccine, ALZ-101 and summarizes her first year as CEO for Alzinova.

Click the image below to see the interview (in Swedish).